Form 4: Disc Medicine CFO Jean M. Franchi Reports Acquisition of 36,000 Shares and Stock Options
SEC Form 4 Filing
Chief Financial Officer Jean M. Franchi reports acquiring 36,000 shares of Disc Medicine, Inc. and stock options, according to a recent SEC Form 4 filing.
Summary
- Jean M. Franchi, the Chief Financial Officer of Disc Medicine, Inc. (IRON), filed a Form 4 with the SEC.
- The filing reports the acquisition of 36,000 shares of common stock on February 10, 2025, granted as restricted stock units (RSUs).
- These RSUs vest in four annual installments starting February 15, 2026, contingent upon continued service.
- Franchi also acquired stock options for 36,000 shares with an exercise price of $54.71, expiring on February 9, 2035.
- These options vest monthly over 48 months beginning March 10, 2025, also subject to continued service.
- Following these transactions, Franchi directly owns 72,666 shares of Disc Medicine.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing reflecting compensation practices. The acquisition of shares and options by the CFO could be seen as a positive signal, but it's not definitively bullish.
Positives
- The acquisition of shares and options by the CFO could be interpreted as a sign of confidence in the company's future prospects.
Future Outlook
The vesting schedules for both the RSUs and stock options are contingent upon the Reporting Person's continued service, suggesting an expectation of continued employment.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into the trading activities of company executives. It is common practice for companies to grant stock options and RSUs to executives as part of their compensation packages.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The vesting schedules incentivize the CFO to remain with the company, potentially benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of transaction for both common stock (RSUs) and stock options. |
| 03/10/2025 | Commencement date for monthly vesting of stock options. |
| 02/15/2026 | Commencement date for annual vesting of restricted stock units (RSUs). |
| 02/09/2035 | Expiration date of the stock options. |
| 02/12/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, insider trading, stock options, restricted stock units, Disc Medicine, IRON, Jean M. Franchi, CFO, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.